jae park, md, on clinical trials for car t-cell activation therapy
Published 8 years ago • 354 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:40
dr. jae park on car t-cell therapy for all
-
1:32
jae park explains car t-cell therapy
-
1:55
dr. jae park on toxicities associated with car-modified t cell therapy
-
1:22
jae h. park, md, on incorporating car-t cell therapies into acute leukemia treatment algorithms
-
4:13
car t-cell therapy clinical trials
-
1:46
dr. jae park on impact of disease burden on car t-cells in relapsed b-all
-
1:22
dr. park discusses use of car t cells in all
-
1:02
dr. park on considerations of car t-cell therapy in relapsed/refractory all
-
1:22
dr. park on cd19-directed car t-cell therapy in patients with all
-
1:57
dr. park on ongoing research efforts with car t-cell therapies in all
-
6:55
jae hong park, md: improving outcomes, minimizing toxicity with car t-cell therapy in b-cell all
-
0:56
dr. park on potential alternate car t-cell targets in b-cell malignancies
-
0:25
copy of dr. park discusses use of car t cells in all
-
2:04
jae h. park, md, on the factors associated with improved survival after cd19 car-t cell therapy
-
1:24
dr. park on using cd19-targeted car t cells as treatment for all
-
0:39
dr. park on challenges with car t cells in aml
-
7:59
car t-cell therapy: real-world applications
-
1:06
car t-cell therapy clinical trials at roswell park
-
6:31
ongoing issues in car t-cell therapy and lymphoma